A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia (Q33392366)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia |
scientific article |
Statements
1 reference
A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia (English)
1 reference
Jaroslaw P Maciejewski
1 reference
Mikkael A Sekeres
1 reference
Harry P Erba
1 reference
Manuel Afable
1 reference
Ricki Englehaupt
1 reference
Ronald Sobecks
1 reference
Anjali Advani
1 reference
Sherry Seel
1 reference
Josephine Chan
1 reference
Matt E Kalaycio
1 reference
19 October 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference